During the past decade, Hospital Universitario Infanta Cristina conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 6 clinical trials were completed, i.e. on average, 16.2% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 2 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Infanta Cristina" #1 sponsor was "Abbott Medical Devices" with 5 trials, followed by "Ipsen" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Shire" with 3 trials sponsored and "Spanish Breast Cancer Research Group" with 3 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Infanta Cristina" #1 collaborator was "Abbott Medical Devices" with 3 trials as a collaborator, "B.Braun Surgical SA" with 2 trials as a collaborator, "Hospital San Carlos, Madrid" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Infanta Cristina" are "Coronary Artery Disease" (5 trials), "Atrial Fibrillation" (2 trials), "Breast Cancer" (2 trials), "Cardiac Arrhythmias" (2 trials) and "Cardiovascular Diseases" (2 trials). Many other conditions were trialed in "Hospital Universitario Infanta Cristina" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Infanta Cristina" are "Drug" (25 trials), "Device" (13 trials), "Procedure" (6 trials), "Biological" (5 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Trastuzumab" (3 trials), "Coronary angioplasty using the paclitaxel-eluting balloon" (2 trials), "Eribulin" (2 trials) and "Letrozole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Infanta Cristina" are 52 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario Infanta Cristina". 1 are not yet recruiting, 12 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Hospital Universitario Infanta Cristina, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Infanta Cristina, 3 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 9 trials that are defined as “Not Applicable".